LIZA CHEN: Open Payments
NPI 1043294275 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,490 in 250 payments from 38 companies in 2025. Trend: 2023 $2,639 · 2024 $3,860 · 2025 $5,490
Food & beverage: $5,212Education: $278
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $640 |
| Janssen Biotech, Inc. | 24 | $599 |
| SOBI, INC | 14 | $444 |
| Astellas Pharma US Inc | 18 | $339 |
| Daiichi Sankyo Inc. | 22 | $329 |
| PFIZER INC. | 10 | $281 |
| GlaxoSmithKline, LLC. | 16 | $268 |
| Exelixis Inc. | 11 | $234 |
| Eisai Inc. | 9 | $230 |
| Novartis Pharmaceuticals Corporation | 13 | $201 |
Products named: Enhertu, CALQUENCE, CABOMETYX, Lenvima, RYBREVANT, KEYTRUDA, Vonjo, OJJAARA.
Industry payments across CA — which companies pay providers there.
